Effects of BufferGel and PRO 2000/5 Gel in Men
NCT00016536 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2021-11-01
Summary
The purpose of this study is to find out if there are any bad effects when BufferGel or PRO 2000/5 Gel are applied to the penis of HIV-infected men.
Microbicides are products to be used by women for placing into the vagina to prevent passing HIV from 1 person to another during sex. Studies have shown 2 investigational microbicides, BufferGel and PRO 2000/5 Gel, to be safe and acceptable for women and HIV-negative men. It is important to see if the side effects of these products are the same in men as those in women and to see if there is any difference in the side effects between circumcised and uncircumcised men.
Conditions
- HIV Infections
Interventions
- DRUG
-
Naphthalene 2-sulfonate polymer
- DRUG
-
Carbopol polymer
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Principal Investigators
-
Connie Celum
Study Design
- Purpose
- PREVENTION
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Completion
- 1997-05-31
Countries
- United States
Study Locations
More Related Trials
-
Interventional Study of Mucosal and Antimicrobial Responses to Repeated Vaginal Applications of Tenofovir Gel in HIV Uninfected Women
NCT00594373 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of Acidform Lubricant in HIV-Uninfected Women
NCT00850837 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Acceptability of a Vaginal Microbicide
NCT00111943 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV Transmission
NCT00213083 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Acceptability of the Anti-Microbe Vaginal Gel, PMPA Gel
NCT00028132 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Nonoxynol-9 (N-9) and HIV Infection
NCT00000926 ·Status: COMPLETED ·Phase: PHASE3
-
Study of UC-781 Vaginal Microbicide
NCT00132444 ·Status: COMPLETED ·Phase: PHASE1
-
Rectal Safety and Acceptability Study of Tenofovir 1% Gel
NCT01232803 ·Status: COMPLETED ·Phase: PHASE1
-
Development of Adherence Biomarkers for Multiple Microbicide and Multipurpose Prevention Technology (MPT) Dosage Forms
NCT02569697 ·Status: COMPLETED ·Phase: PHASE1
-
An Imaging Trial of the Distribution of Topical Gel Formulations in the Human Vagina
NCT00214747 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety, Tolerance and Acceptability Trial of the Invisible Condom® in Healthy Women
NCT00136643 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women
NCT01230814 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Acceptability Study of the UC-781 Microbicide Gel Applied Rectally
NCT00408538 ·Status: COMPLETED ·Phase: PHASE1
-
OB-002H Gel Administered Vaginally and Rectally in HIV-1 Seronegative Adults
NCT04791007 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluating the Safety of Tenofovir Vaginal Gel in HIV-Uninfected Pregnant Women
NCT01490671 ·Status: WITHDRAWN ·Phase: PHASE2
-
Trial of SAVVY Vaginal Gel and HIV in Nigeria
NCT00130078 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study to Compare Three Different Formulations of Tenofovir 1% Gel When Administered Rectally
NCT01575405 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study of UC-781 Vaginal Microbicide
NCT00446979 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of BufferGel as a Vaginal Contraceptive
NCT00065858 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Cellulose Sulfate and HIV Transmission Among Women
NCT00153777 ·Status: TERMINATED ·Phase: PHASE3
-
Tenofovir Levels Following Local Application of Tenofovir Reduced-Glycerin 1% Gel
NCT01768962 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety of Griffithsin in a Carrageenan Gel in Healthy Women
NCT02875119 ·Status: COMPLETED ·Phase: PHASE1
-
Postcoital Testing of the SILCS Diaphragm
NCT00561613 ·Status: COMPLETED ·Phase: PHASE1
-
Coital Pharmacokinetics/Pharmacodynamics (PK/PD) of Tenofovir Gel
NCT01687205 ·Status: COMPLETED ·Phase: PHASE1
-
In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products
NCT01813162 ·Status: COMPLETED ·Phase: PHASE1